LOC100652743: A Drug Target / Disease Biomarker (G100652743)
LOC100652743: A Drug Target / Disease Biomarker
LOC100652743 is a protein that is expressed in various tissues of the body, including the brain, heart, liver, and muscle. It is a member of the LOC100652743 family, which is characterized by the presence of a unique catalytic domain in the N-terminus of the protein.
The catalytic domain is a structural region that is responsible for the catalytic activity of the protein. It is composed of a Rossmann-fold, a尾-sheet, and a 尾-hairpin, which give it a specific 3D structure that allows it to interact with small molecules, such as drugs, toxins, and other biomolecules.
LOC100652743 is a potential drug target because of its catalytic activity and the fact that it is expressed in many different tissues of the body. It is also expressed in the brain, which is a known hub for drug development and drug action.
One of the potential benefits of targeting LOC100652743 is that it can modulate the activity of other proteins, which can have a therapeutic effect on a wide range of diseases. For example, LOC100652743 has been shown to play a role in the regulation of cellular signaling pathways, which can be important for a variety of diseases, including cancer, neurodegenerative diseases, and mood disorders.
Targeting LOC100652743 may also have the advantage of being less risky than some other drug development strategies. For example, blocking a protein that is involved in many different cellular processes may have unintended consequences for other parts of the body. By targeting LOC100652743 specifically, researchers can focus on modulating its activity without affecting other proteins.
In addition to its potential therapeutic benefits, LOC100652743 is also a valuable biomarker for a variety of diseases. Its expression has been shown to be associated with a range of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. By detecting the expression of LOC100652743 in biological samples from patients with these diseases, researchers can develop biomarkers that can be used for diagnostic purposes and for monitoring the effectiveness of treatments.
Overall, LOC100652743 is a promising drug target and a valuable biomarker for a variety of diseases. Further research is needed to fully understand its role in cellular signaling pathways and its potential as a therapeutic agent.
Protein Name: Ig Kappa Chain V-III Region VH-like Pseudogene
More Common Targets
LOC100652768 | LOC100652833 | LOC100652999 | LOC100653061 | LOC100996385 | LOC100996412 | LOC100996583 | LOC100996637 | LOC100996643 | LOC100996664 | LOC100996770 | LOC101060017 | LOC101060106 | LOC101060179 | LOC101060400 | LOC101060445 | LOC101060524 | LOC101060632 | LOC101448202 | LOC101593348 | LOC101926887 | LOC101926948 | LOC101926953 | LOC101926959 | LOC101926969 | LOC101927002 | LOC101927020 | LOC101927025 | LOC101927026 | LOC101927040 | LOC101927053 | LOC101927060 | LOC101927066 | LOC101927082 | LOC101927108 | LOC101927143 | LOC101927164 | LOC101927166 | LOC101927169 | LOC101927179 | LOC101927188 | LOC101927199 | LOC101927216 | LOC101927243 | LOC101927245 | LOC101927253 | LOC101927263 | LOC101927269 | LOC101927314 | LOC101927369 | LOC101927394 | LOC101927421 | LOC101927476 | LOC101927483 | LOC101927495 | LOC101927518 | LOC101927531 | LOC101927548 | LOC101927550 | LOC101927571 | LOC101927588 | LOC101927598 | LOC101927605 | LOC101927609 | LOC101927627 | LOC101927636 | LOC101927668 | LOC101927712 | LOC101927727 | LOC101927741 | LOC101927745 | LOC101927770 | LOC101927787 | LOC101927825 | LOC101927827 | LOC101927834 | LOC101927840 | LOC101927853 | LOC101927855 | LOC101927857 | LOC101927863 | LOC101927896 | LOC101927897 | LOC101927910 | LOC101927932 | LOC101927942 | LOC101927947 | LOC101927960 | LOC101927967 | LOC101927971 | LOC101927995 | LOC101927998 | LOC101928004 | LOC101928007 | LOC101928008 | LOC101928012 | LOC101928014 | LOC101928047 | LOC101928053 | LOC101928080
